About Cantel Medical (NYSE:CMD)
Cantel Medical Corp. provides infection prevention products and services for the healthcare market worldwide. The company operates through four segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services. The Water Purification and Filtration segment provides water purification systems; bicarbonate systems; hollow fiber filters; filtration and separation, liquid disinfectants and cold sterilization, and dry fog products; and room temperature sterilizers for the dialysis and specific healthcare applications, research laboratories and pharmaceutical, food and beverage, and commercial industrial customers. The Healthcare Disposables segment offers biological and chemical integrators, sterilization pouches, towels, bibs, tray liners and sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, shields, hand sanitizers, germicidal wipes, surface disinfectants, saliva ejectors, evacuator tips and plastic cups, and prophy angles and pastes, as well as waterline treatment products for maintaining safe dental unit waterlines. The Dialysis segment provides medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates, and other supplies for renal dialysis. The company sells its products through its direct distribution network in the United States; and directly or under third-party distribution agreements internationally. The company was founded in 1963 and is headquartered in Little Falls, New Jersey.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNYSE:CMD
CUSIPN/A
Phone973-890-7220
Debt
Debt-to-Equity Ratio0.27%
Current Ratio2.58%
Quick Ratio1.57%
Price-To-Earnings
Trailing P/E Ratio55.70
Forward P/E Ratio46.44
P/E GrowthN/A
Sales & Book Value
Annual Sales$770.16 million
Price / Sales6.29
Cash Flow$2.9171 per share
Price / Cash39.80
Book Value$12.56 per share
Price / Book9.24
Profitability
EPS (Most Recent Fiscal Year)$2.08
Net Income$71.37 million
Net Margins10.92%
Return on Equity17.18%
Return on Assets11.19%
Miscellaneous
Employees2,337
Outstanding Shares41,710,000
Cantel Medical (NYSE:CMD) Frequently Asked Questions
What is Cantel Medical's stock symbol?
Cantel Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "CMD."
How often does Cantel Medical pay dividends? What is the dividend yield for Cantel Medical?
Cantel Medical announced a Semi-Annual dividend on Wednesday, November 1st. Investors of record on Wednesday, January 17th will be given a dividend of $0.085 per share on Wednesday, January 31st. This represents a yield of 0.17%. The ex-dividend date is Tuesday, January 16th. This is a boost from Cantel Medical's previous Semi-Annual dividend of $0.07. View Cantel Medical's Dividend History.
How were Cantel Medical's earnings last quarter?
Cantel Medical Co. (NYSE:CMD) released its quarterly earnings data on Thursday, March, 8th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.58 by $0.01. The company had revenue of $213.03 million for the quarter, compared to analysts' expectations of $210.60 million. Cantel Medical had a net margin of 10.92% and a return on equity of 17.18%. View Cantel Medical's Earnings History.
When is Cantel Medical's next earnings date?
What price target have analysts set for CMD?
3 equities research analysts have issued 1-year price targets for Cantel Medical's stock. Their predictions range from $92.00 to $92.00. On average, they expect Cantel Medical's stock price to reach $92.00 in the next twelve months. View Analyst Ratings for Cantel Medical.
What are Wall Street analysts saying about Cantel Medical stock?
Here are some recent quotes from research analysts about Cantel Medical stock:
- 1. According to Zacks Investment Research, "Cantel Medical Corp. is a healthcare company concentrating primarily in infection prevention and control products and diagnostic and therapeutic medical equipment. Through its United States subsidiary, MediVators, Inc., Cantel serves customers worldwide by designing, developing, manufacturing, marketing and distributing innovative products for the infection prevention and control industry. " (8/8/2017)
- 2. Needham & Company LLC analysts commented, "CMD’s F3Q17 revenue and EPS met consensus. Overall organic revenue growth slowed to 7.4% CC in F3Q17 from 12.1% CC in F2Q17 due mainly to a difficult comp. Endoscopy growth slowed from F2Q17 as expected; its 9% growth was just below our 10% estimate but we consider this to be a solid result considering that CMD was up against a 44% comp in F3Q16 (driven, in part, by the Custom Ultrasonics recall). Water Purification & Filtration and Healthcare Disposables growth also slowed from F2Q17. Adjusted gross margin was up 130 bps Y/Y due to product mix and cost improvements and this marked the 14th consecutive quarter of Y/ Y gross margin improvement. We maintain our Hold given CMD’s slower organic growth and valuation (CY17E P/E of 35.7x vs. small/mid-cap GARP peers at 27.9x)." (6/8/2017)
Who are some of Cantel Medical's key competitors?
Some companies that are related to Cantel Medical include Dexcom (DXCM), Hill-Rom (HRC), Insulet (PODD), ICU Medical (ICUI), Globus Medical (GMED), Penumbra (PEN), Haemonetics (HAE), Nevro (NVRO), NuVasive (NUVA), Merit Medical Systems (MMSI), NovoCure (NVCR), Mazor Robotics (MZOR), Irhythm Technologies (IRTC), Intersect ENT (XENT), ATRION (ATRI), Orthofix (OFIX), OraSure Technologies (OSUR) and Glaukos (GKOS).
Who are Cantel Medical's key executives?
Cantel Medical's management team includes the folowing people:
- Mr. Charles M. Diker, Chairman and Member of Office of the Chairman
- Mr. Jorgen B. Hansen, CEO, Pres, Member of Office of the Chairman & Director
- Mr. Peter G. Clifford, Exec. VP, CFO & Member of Office of the Chairman
- Mr. Eric W. Nodiff, Exec. VP, Gen. Counsel, Corp. Sec. & Member of Office of the Chairman
- Mr. Seth M. Yellin, Exec. VP of Strategy & Corp. Devel. and Member of Office of the Chairman
Has Cantel Medical been receiving favorable news coverage?
News stories about CMD stock have trended somewhat positive recently, Accern reports. The research firm scores the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cantel Medical earned a media sentiment score of 0.04 on Accern's scale. They also gave media stories about the company an impact score of 46.33 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
How do I buy shares of Cantel Medical?
Shares of CMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cantel Medical's stock price today?
One share of CMD stock can currently be purchased for approximately $116.10.
How big of a company is Cantel Medical?
Cantel Medical has a market capitalization of $4.80 billion and generates $770.16 million in revenue each year. The company earns $71.37 million in net income (profit) each year or $2.08 on an earnings per share basis. Cantel Medical employs 2,337 workers across the globe.
How can I contact Cantel Medical?
Cantel Medical's mailing address is 150 CLOVE ROAD, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-890-7220 or via email at [email protected]
MarketBeat Community Rating for Cantel Medical (CMD)
MarketBeat's community ratings are surveys of what our community members think about Cantel Medical and other stocks. Vote "Outperform" if you believe CMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
Cantel Medical (NYSE:CMD) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for Cantel Medical in the last 12 months. Their average twelve-month price target is $92.00, suggesting that the stock has a possible downside of 20.76%. The high price target for CMD is $92.00 and the low price target for CMD is $92.00. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.33 | 2.33 | 2.25 | 2.25 |
| Ratings Breakdown: | 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $92.00 | $92.00 | $92.00 | $96.00 |
| Price Target Upside: | 20.76% downside | 13.23% upside | 13.23% upside | 18.15% upside |
Cantel Medical (NYSE:CMD) Consensus Price Target History
Cantel Medical (NYSE:CMD) Analyst Ratings History
Show:
(Data available from 4/20/2016 forward)
Cantel Medical (NYSE:CMD) Dividend Information
Cantel Medical pays an annual dividend of $0.17 per share, with a dividend yield of 0.15%. CMD's most recent semi-annual dividend payment was Wednesday, January 31. Cantel Medical pays out 8.17% of its earnings out as a dividend.
| Most Recent Dividend: | 1/31/2018 |
| Annual Dividend: | $0.17 |
| Dividend Yield: | 0.15% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio: | 8.17% (Trailing 12 Months of Earnings)
6.80% (Based on This Year's Estimates)
5.76% (Based on Next Year's Estimates)
|
Cantel Medical (NYSE:CMD) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 11/1/2017 | Semi-Annual | $0.0850 | 0.17% | 1/16/2018 | 1/17/2018 | 1/31/2018 |
| 6/29/2017 | semiannual | $0.07 | 0.18% | 7/13/2017 | 7/17/2017 | 7/31/2017 |
| 10/14/2016 | | $0.07 | | 1/12/2017 | 1/17/2017 | 1/31/2017 |
(Data available from 1/1/2013 forward)
Cantel Medical (NYSE CMD) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 12.30%
Institutional Ownership Percentage: 85.19%
Cantel Medical (NYSE CMD) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 10/20/2017 | Eric W Nodiff | EVP | Sell | 2,868 | $97.55 | $279,773.40 | 39,102 |  |
| 10/13/2017 | George L Fotiades | Director | Sell | 6,000 | $95.23 | $571,380.00 | | |
| 10/4/2017 | Charles M Diker | Chairman | Sell | 20,500 | $99.15 | $2,032,575.00 | | |
| 10/3/2017 | Mark N Diker | Director | Sell | 7,000 | $98.90 | $692,300.00 | | |
| 7/12/2017 | Charles M Diker | Chairman | Sell | 35,000 | $75.52 | $2,643,200.00 | 3,114,520 | |
| 6/12/2017 | Charles M Diker | Chairman | Sell | 13,000 | $76.36 | $992,680.00 | 3,124,222 | |
| 4/7/2017 | Eric W Nodiff | EVP | Sell | 1,500 | $74.18 | $111,270.00 | 44,900 | |
| 3/15/2017 | Anthony B Evnin | Director | Buy | 2,500 | $77.88 | $194,700.00 | 5,762 | |
| 1/19/2017 | Eric W Nodiff | EVP | Sell | 1,117 | $76.68 | $85,651.56 | 46,400 | |
| 1/18/2017 | Anthony B Evnin | Director | Buy | 2,000 | $76.26 | $152,520.00 | 3,262 | |
(Data available from 1/1/2013 forward)
Cantel Medical (NYSE CMD) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Cantel Medical (CMD) Announces FDA 510(k) Clearance to Market ADVANTAGE PLUS Pass-Thru Automated Endoscope Reprocessor
www.streetinsider.com - April 19 at 9:39 AM |
 | Brokerages Expect Cantel Medical Co. (CMD) to Post $0.59 Earnings Per Share
www.americanbankingnews.com - April 14 at 9:28 PM |
| Cantel Medical (CMD) Rating Increased to Buy at Sidoti
www.americanbankingnews.com - April 14 at 10:43 AM |
| Cantel Medical (CMD) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - April 12 at 5:09 PM |
| Analyzing Cantel Medical (CMD) and Its Rivals
www.americanbankingnews.com - April 7 at 12:01 PM |
| Analysts Set $135.00 Price Target for Cantel Medical Corp. (CMD)
www.americanbankingnews.com - March 30 at 3:36 AM |
| Zacks: Cantel Medical Corp. (CMD) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - March 26 at 11:10 PM |
| Cantel Medical (CMD) versus Its Rivals Financial Analysis
www.americanbankingnews.com - March 26 at 5:25 AM |
| Cantel Medical (CMD) Acquires Aexis Medical for $24.8 Million
www.streetinsider.com - March 21 at 4:14 PM |
 | Cantel Medical to Participate in Fireside Chat at the 17th Annual Needham & Company Healthcare Conference
finance.yahoo.com - March 19 at 4:13 PM |
| Cantel Medical Corp. (CMD) Given $135.00 Consensus Target Price by Brokerages
www.americanbankingnews.com - March 19 at 5:52 AM |
| Reviewing Cantel Medical (CMD) and Stryker (SYK)
www.americanbankingnews.com - March 18 at 9:12 PM |
| Cantel Medical Reports a Solid Quarter While Saying Thanks to Uncle Sam
finance.yahoo.com - March 12 at 5:21 PM |
| Cantel Medical Reports Record Financial Results for its Second Quarter Fiscal Year 2018
finance.yahoo.com - March 8 at 5:08 PM |
| Has Cantel Medical Corp (NYSE:CMD) Got Enough Cash To Cover Its Short-Term Obligations?
finance.yahoo.com - March 8 at 10:03 AM |
| Cantel Medical Corp. (CMD) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - March 4 at 12:14 PM |
| Cantel Medical (CMD) to Release Earnings on Thursday
www.americanbankingnews.com - March 1 at 1:46 AM |
| Cantel Medical Corp. (CMD) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - February 28 at 1:26 AM |
| Cantel Medical Promotes Lawrence Conway to Senior Vice President, Business Systems and Integration
finance.yahoo.com - February 14 at 9:03 AM |
| Zacks: Cantel Medical Corp. (CMD) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - February 13 at 10:54 AM |
| Analysts Anticipate Cantel Medical Corp. (CMD) to Post $0.58 EPS
www.americanbankingnews.com - January 29 at 11:38 AM |
 | iShares Core S&P Small-Cap ETF Experiences Big Outflow
www.nasdaq.com - January 26 at 4:32 PM |
| Free Post Earnings Research Report: Cantel Medical’s Sales Jumped 13.3%; EPS Surged 21.9%
finance.yahoo.com - January 8 at 9:30 AM |
| Cantel Medical Corp. (CMD) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - December 30 at 5:38 PM |
| Cantel Medical to Present at the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 28 at 3:39 PM |
| Zacks: Cantel Medical Corp. (CMD) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - December 15 at 1:48 AM |
| ETFs with exposure to Cantel Medical Corp. : December 12, 2017
finance.yahoo.com - December 12 at 5:22 PM |
| Cantel Medical Corp. :CMD-US: Earnings Analysis: Q1, 2018 By the Numbers : December 11, 2017
finance.yahoo.com - December 11 at 5:09 PM |
| Cantel Medical Joins Elite Club Of Stocks With RS Ratings Over 90
finance.yahoo.com - December 8 at 4:54 PM |
| Cantel Medical Corp. Keeps Pace on Its Goal
finance.yahoo.com - December 8 at 4:54 PM |
| Investor Network Invites You to the Cantel Medical Corp. First Quarter 2018 Earnings Conference Call and Webcast Live on Thursday, December 7, 2017
finance.yahoo.com - December 6 at 5:00 PM |
| Cantel Medical Just Within Buy Range As Earnings Approach
finance.yahoo.com - December 5 at 4:56 PM |
| Cantel Medical (CMD) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - November 30 at 1:30 AM |
| Analysts Anticipate Cantel Medical Corp. (CMD) to Post $0.52 Earnings Per Share
www.americanbankingnews.com - November 27 at 1:38 AM |
| IJT, CMD, JBT, LITE: Large Outflows Detected at ETF
www.nasdaq.com - November 21 at 10:32 PM |
 | Cantel Medical (CMD) Presents At Jefferies 2017 London Healthcare Conference - Slideshow
seekingalpha.com - November 17 at 9:33 PM |
| No. 1-Ranked Medical Stock Near Breakout With Earnings Due
finance.yahoo.com - November 13 at 10:39 PM |
| Zacks: Cantel Medical Corp. (CMD) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - November 12 at 5:46 AM |
| ETFs with exposure to Cantel Medical Corp. : November 9, 2017
finance.yahoo.com - November 9 at 8:12 PM |
| Cantel Medical to Present at the Jefferies 2017 London Healthcare Conference
finance.yahoo.com - November 2 at 6:12 PM |
| Cantel Medical Corp. (CMD) Announces Semi-Annual Dividend of $0.09
www.americanbankingnews.com - November 2 at 11:52 AM |
| Cantel Medical Announces 21% Increase In Semiannual Dividend
finance.yahoo.com - November 1 at 6:09 PM |
| Cantel Medical Corp. (CMD) Short Interest Update
www.americanbankingnews.com - November 1 at 2:40 AM |
| Cantel Medical Corp. (CMD) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - October 28 at 5:30 PM |
| Eric W. Nodiff Sells 2,868 Shares of Cantel Medical Corp. (CMD) Stock
www.americanbankingnews.com - October 23 at 7:28 PM |
| Zacks: Cantel Medical Corp. (CMD) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - October 21 at 4:24 AM |
| Cantel Medical Corp. (CMD) Director Sells $571,380.00 in Stock
www.americanbankingnews.com - October 17 at 1:16 PM |
| ETFs with exposure to Cantel Medical Corp. : October 16, 2017
finance.yahoo.com - October 16 at 6:05 PM |
 | Pro-Trader Daily: Earnings Review and Free Research Report: Cantel Medical's Adjusted EPS Increased 12.5%
www.finanznachrichten.de - October 10 at 11:35 PM |
| Earnings Review and Free Research Report: Cantel Medical’s Adjusted EPS Increased 12.5%
finance.yahoo.com - October 10 at 6:32 PM |
Cantel Medical (NYSE:CMD) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Cantel Medical (NYSE:CMD) Income Statement, Balance Sheet and Cash Flow Statement
Cantel Medical (NYSE CMD) Stock Chart for Friday, April, 20, 2018
Loading chart…
